on Twitter Gerald responded to someone who has
Post# of 30027
(Total Views: 480)
Posted On: 09/23/2020 1:11:00 PM
on Twitter
Gerald responded to someone who has zero credibility...
The poster speaks as if they have any clue to what's truly happening and always in terms of
"The Market, says, believes or thinks..."
Are the contracts real? That's their first question wrapped in a foolish statement.
"The market believes nay"
Armchair CEO at its worst.... telling people that Gerlad is announcing fake contracts to the SEC ?
Their statement...
"I don’t think the market believes these contracts are legit..."
Gerald Commissiong@G_Commish
Well they are real, and there will be more. The issues from March and April remain and we are a significant emerging 2nd source supplier for those who cannot get the necessary reagents from the major players. COVID testing is still a major problem
Then they go one to admit they don't understand..
"just trying to understand this...."
Gerald Commissiong@G_Commish
It’s disappointing when hard work isn’t rewarded. With that said, our work is ongoing. It’s clear the market wants clarity on uplist plans which is reasonable. Generating future revenues is extremely important and we now have a strong base pro forma which strengthens our position
There is more, but so unworthy of giving any recognition to anyone that has such a rudimentary understanding yet, always speaks in terms of their own factual "opinions" .
Gerald responded to someone who has zero credibility...
The poster speaks as if they have any clue to what's truly happening and always in terms of
"The Market, says, believes or thinks..."
Are the contracts real? That's their first question wrapped in a foolish statement.
"The market believes nay"
Armchair CEO at its worst.... telling people that Gerlad is announcing fake contracts to the SEC ?
Their statement...
"I don’t think the market believes these contracts are legit..."
Gerald Commissiong@G_Commish
Well they are real, and there will be more. The issues from March and April remain and we are a significant emerging 2nd source supplier for those who cannot get the necessary reagents from the major players. COVID testing is still a major problem
Then they go one to admit they don't understand..
"just trying to understand this...."
Gerald Commissiong@G_Commish
It’s disappointing when hard work isn’t rewarded. With that said, our work is ongoing. It’s clear the market wants clarity on uplist plans which is reasonable. Generating future revenues is extremely important and we now have a strong base pro forma which strengthens our position
There is more, but so unworthy of giving any recognition to anyone that has such a rudimentary understanding yet, always speaks in terms of their own factual "opinions" .
(0)
(1)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼